ExploreWatchlistsPricing
  1. JP-listed companies
  2. ONO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Total cash & short-term investments

ONO PHARMACEUTICAL CO., LTD. (4528)

Market cap
¥1.18T
P/E ratio
16.5x
Japanese pharmaceutical company that develops, manufactures and sells prescription and over-the-counter drugs through a global network of 26 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 2025205,901+0.64%
Mar 31, 2024204,595+24.55%
Mar 31, 2023164,269+40.51%
Mar 31, 2022116,909+14.62%
Mar 31, 2021101,997+2.20%
Mar 31, 202099,805+41.01%
Mar 31, 201970,781-8.12%
Mar 31, 201877,037-51.20%
Mar 31, 2017157,870+24.67%
Mar 31, 2016126,630+4.00%
Mar 31, 2015121,756

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat